+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 0 - 18Years
All Genders
ID07029230

Study of sST2 Blood Marker to Predict Heart Failure in Children Undergoing Congenital Heart Surgery

Led by Martin Schweiger · Updated on 2025-11-17

225

Participants Needed

1

Research Sites

56 weeks

Total Duration

AI-Summary

What This Trial Is About

This research focuses on children under 18 years old scheduled for congenital heart surgery. It aims to evaluate the usefulness of a new blood biomarker called soluble suppression of tumorigenicity 2 sST2 in predicting heart failure. The study compares sST2 to other established biomarkers, seeking to improve risk assessment and management for pediatric patients with congenital heart disease, a common birth defect that can lead to serious heart complications after surgery. Participants are children planned for congenital cardiac surgery. Blood samples for sST2 and other biomarkers will be collected during surgery, post-operatively, and again at a follow-up visit 9 to 12 months later. The study observes the levels of sST2 independently and alongside other markers to assess its reliability, as sST2 may be less affected by factors like age or acute kidney injury. Throughout the study, patients will be monitored for signs of heart failure through clinical data, cardiac imaging, and hospital records within the first year after surgery. Researchers will track outcomes such as mortality, length of hospital stay, time on ventilation, ICU stay, and unplanned readmissions. The main measurement is the presence of heart failure signs one year after surgery, helping to better predict long-term risks for these children.

CONDITIONS

Brief Title

Blood Based Assessment of sST2, Taken During and After Surgery, for Pediatric Patients With Heart Defects to Predict Heart Failure.

Research Team

M

Martin Schweiger, Prof, MD, MBA

C

Clemens Haselmann, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here